Xingqi Eye Medicine (300573.SZ): The first subject enrolled in the Phase II clinical trial of Fudikangzuo eye drops.

Zhtng Finance APP News, Xngq Ynyo (300573.SZ) announced that the company's research and development of the eye drops Flkngzng has completed the first subject enrollment today, officially entering Phase II clinical trials.